Effect of genetic polymorphisms of vascular endothelial growth factor on left ventricular hypertrophy in patients with systemic hypertension

American Journal of Cardiology

Volumn 113, Issue 3, 2014, Pages 491-496

  Lacchini, Riccardo ^a   Luizon, Marcelo Rizzatti ^a   Gasparini, Sandra ^b   Ferreira Sae, Maria C ^b   Schreiber, Roberto ^b   Nadruz, Wilson ^b   Tanus Santos, Jose E ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ADULT; ALLELE; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROMOTER REGION;

DISEASE PROGRESSION; DNA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84892617890     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.10.034     Document Type: Article

References (30)

1. R.A. De Boer, Y.M. Pinto, and D.J. Van Veldhuisen The imbalance between oxygen demand and supply as a potential mechanism in the pathophysiology of heart failure: the role of microvascular growth and abnormalities Microcirculation 10 2003 113 126
2. I. Shiojima, K. Sato, Y. Izumiya, S. Schiekofer, M. Ito, R. Liao, W.S. Colucci, and K. Walsh Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure J Clin Invest 115 2005 2108 2118
3. Y. Izumiya, I. Shiojima, K. Sato, D.B. Sawyer, W.S. Colucci, and K. Walsh Vascular endothelial growth factor blockade promotes the transition from compensatory cardiac hypertrophy to failure in response to pressure overload Hypertension 47 2006 887 893
4. S. Givvimani, N. Tyagi, U. Sen, P.K. Mishra, N. Qipshidze, C. Munjal, J.C. Vacek, O.A. Abe, and S.C. Tyagi MMP-2/TIMP-2/TIMP-4 versus MMP-9/TIMP-3 in transition from compensatory hypertrophy and angiogenesis to decompensatory heart failure Arch Physiol Biochem 116 2010 63 72
5. M. Sano, T. Minamino, H. Toko, H. Miyauchi, M. Orimo, Y. Qin, H. Akazawa, K. Tateno, Y. Kayama, M. Harada, I. Shimizu, T. Asahara, H. Hamada, S. Tomita, J.D. Molkentin, Y. Zou, and I. Komuro p53-Induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload Nature 446 2007 444 448
6. N. Ferrara Vascular endothelial growth factor Arterioscler Thromb Vasc Biol 29 2009 789 791
7. D.I. Holmes, and I. Zachary The vascular endothelial growth factor (VEGF) family: angiogenic factors in health and disease Genome Biol 6 2005 209
8. F.J. Giordano, H.P. Gerber, S.P. Williams, N. VanBruggen, S. Bunting, P. Ruiz-Lozano, Y. Gu, A.K. Nath, Y. Huang, R. Hickey, N. Dalton, K.L. Peterson, J. Ross Jr., K.R. Chien, and N. Ferrara A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function Proc Natl Acad Sci U S A 98 2001 5780 5785
9. D. Lambrechts, E. Storkebaum, M. Morimoto, J. Del-Favero, F. Desmet, S.L. Marklund, S. Wyns, V. Thijs, J. Andersson, I. van Marion, A. Al-Chalabi, S. Bornes, R. Musson, V. Hansen, L. Beckman, R. Adolfsson, H.S. Pall, H. Prats, S. Vermeire, P. Rutgeerts, S. Katayama, T. Awata, N. Leigh, L. Lang-Lazdunski, M. Dewerchin, C. Shaw, L. Moons, R. Vlietinck, K.E. Morrison, W. Robberecht, C. Van Broeckhoven, D. Collen, P.M. Andersen, and P. Carmeliet VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death Nat Genet 34 2003 383 394
10. M. Shahbazi, A.A. Fryer, V. Pravica, I.J. Brogan, H.M. Ramsay, I.V. Hutchinson, and P.N. Harden Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection J Am Soc Nephrol 13 2002 260 264
11. F.M. Goncalves, A. Martins-Oliveira, J.G. Speciali, T.C. Izidoro-Toledo, M.R. Luizon, F. Dach, and J.E. Tanus-Santos Vascular endothelial growth factor genetic polymorphisms and haplotypes in women with migraine DNA Cell Biol 29 2010 357 362
12. V.C. Sandrim, A.C. Palei, R.C. Cavalli, F.M. Araujo, E.S. Ramos, G. Duarte, and J.E. Tanus-Santos Vascular endothelial growth factor genotypes and haplotypes are associated with pre-eclampsia but not with gestational hypertension Mol Hum Reprod 15 2009 115 120
13. W.M. Howell, S. Ali, M.J. Rose-Zerilli, and S. Ye VEGF polymorphisms and severity of atherosclerosis J Med Genet 42 2005 485 490
14. M.L. Sales, M.C. Ferreira, C.A. Leme Jr., L.A. Velloso, M.C. Gallani, R.C. Colombo, K.G. Franchini, and W. Nadruz Jr. Non-effect of p22-phox -930A/G polymorphism on end-organ damage in Brazilian hypertensive patients J Hum Hypertens 21 2007 504 506
15. R.M. Lang, M. Bierig, R.B. Devereux, F.A. Flachskampf, E. Foster, P.A. Pellikka, M.H. Picard, M.J. Roman, J. Seward, J. Shanewise, S. Solomon, K.T. Spencer, M. St John Sutton, and W. Stewart Recommendations for chamber quantification Eur J Echocardiogr 7 2006 79 108
16. M.S. Lauer, K.M. Anderson, M.G. Larson, and D. Levy A new method for indexing left ventricular mass for differences in body size Am J Cardiol 74 1994 487 491
17. J.J. Muniz, T.C. Izidoro-Toledo, I.F. Metzger, V.C. Sandrim, and J.E. Tanus-Santos Interethnic differences in the distribution of clinically relevant vascular endothelial growth factor genetic polymorphisms DNA Cell Biol 28 2009 567 572
18. M. Miyachi, H. Yazawa, M. Furukawa, K. Tsuboi, M. Ohtake, T. Nishizawa, K. Hashimoto, T. Yokoi, T. Kojima, T. Murate, M. Yokota, T. Murohara, Y. Koike, and K. Nagata Exercise training alters left ventricular geometry and attenuates heart failure in dahl salt-sensitive hypertensive rats Hypertension 53 2009 701 707
19. C.M. Bloor Angiogenesis during exercise and training Angiogenesis 8 2005 263 271
20. E. Kaza, K. Ablasser, D. Poutias, E.R. Griffiths, F.A. Saad, J.G. Hofstaetter, P.J. del Nido, and I. Friehs Up-regulation of soluble vascular endothelial growth factor receptor-1 prevents angiogenesis in hypertrophied myocardium Cardiovasc Res 89 2011 410 418
21. I. Friehs, R.E. Margossian, A.M. Moran, H. Cao-Danh, M.A. Moses, and P.J. del Nido Vascular endothelial growth factor delays onset of failure in pressure-overload hypertrophy through matrix metalloproteinase activation and angiogenesis Basic Res Cardiol 101 2006 204 213
22. I. Friehs, A.M. Moran, C. Stamm, Y.H. Choi, D.B. Cowan, F.X. McGowan, and P.J. del Nido Promoting angiogenesis protects severely hypertrophied hearts from ischemic injury Ann Thorac Surg 77 2004 2004 2010 discussion 2011
23. M. Pepe, M. Mamdani, L. Zentilin, A. Csiszar, K. Qanud, S. Zacchigna, Z. Ungvari, U. Puligadda, S. Moimas, X. Xu, J.G. Edwards, T.H. Hintze, M. Giacca, and F.A. Recchia Intramyocardial VEGF-B167 gene delivery delays the progression towards congestive failure in dogs with pacing-induced dilated cardiomyopathy Circ Res 106 2010 1893 1903
24. D. Zisa, A. Shabbir, M. Mastri, G. Suzuki, and T. Lee Intramuscular VEGF repairs the failing heart: role of host-derived growth factors and mobilization of progenitor cells Am J Physiol Regul Integr Comp Physiol 297 2009 R1503 R1515
25. P. Carmeliet, Y.S. Ng, D. Nuyens, G. Theilmeier, K. Brusselmans, I. Cornelissen, E. Ehler, V.V. Kakkar, I. Stalmans, V. Mattot, J.C. Perriard, M. Dewerchin, W. Flameng, A. Nagy, F. Lupu, L. Moons, D. Collen, P.A. D'Amore, and D.T. Shima Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188 Nat Med 5 1999 495 502
26. D. Tirziu, E. Chorianopoulos, K.L. Moodie, R.T. Palac, Z.W. Zhuang, M. Tjwa, C. Roncal, U. Eriksson, Q. Fu, A. Elfenbein, A.E. Hall, P. Carmeliet, L. Moons, and M. Simons Myocardial hypertrophy in the absence of external stimuli is induced by angiogenesis in mice J Clin Invest 117 2007 3188 3197
27. C. Demacq, V.B. Vasconcellos, T.C. Izidoro-Toledo, V. da Silva Silveira, R. Canalle, R.G. Queiroz, L.G. Tone, and J.E. Tanus-Santos Vascular endothelial growth factor (VEGF) and endothelial nitric oxide synthase (NOS3) polymorphisms are associated with high relapse risk in childhood acute lymphoblastic leukemia (ALL) Clin Chim Acta 411 2010 1335 1340
28. R. Lacchini, J.J. Muniz, Y.T. Nobre, A.J. Cologna, A.C. Martins, and J.E. Tanus-Santos VEGF genetic polymorphisms affect the responsiveness to sildenafil in clinical and postoperative erectile dysfunction Pharmacogenomics J 13 2013 437 442
29. V.C. Sandrim, M.R. Luizon, T.C. Izidoro-Toledo, E.B. Coelho, H. Moreno Jr., and J.E. Tanus-Santos Functional VEGF haplotypes affect the susceptibility to hypertension J Hum Hypertens 27 2013 31 37
30. R. Vidavalur, S.V. Penumathsa, L. Zhan, M. Thirunavukkarasu, and N. Maulik Sildenafil induces angiogenic response in human coronary arteriolar endothelial cells through the expression of thioredoxin, hemeoxygenase and vascular endothelial growth factor Vascul Pharmacol 45 2006 91 95